See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $9.5B | 7.8x | 22.2x | |
| $9.3B | n/a | n/a | |
| $2.0B | 7.9x | -184.7x | |
| $1.3B | 4.5x | -10.3x | |
| $1.2B | n/a | n/a | |
| $458M | 243.8x | -14.5x | |
| $345M | n/a | n/a | |
| $175M | 57.1x | -9.0x | |
| $170M | 3.3x | 18.9x | |
| $139M | 8.2x | 10.7x | |
| $136M | n/a | -2.1x | |
| $66.1M | 6.0x | -3.7x | |
| $53.6M | 3.0x | 16.2x | |
| $40.4M | 1.5x | n/a | |
| $33.4M | 40.5x | -13.1x | |
| $28.1M | 11.3x | -5.8x | |
| $22.5M | 13.3x | -14.4x | |
| $4.3M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics